Charanjit Aulakh

Array ( [id] => 7699588 [patent_doc_number] => 20110227002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'AROMATIC IMIDE-BASED DISPERSANT FOR CARBON NANOTUBES AND CARBON NANOTUBE COMPOSITION COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/152600 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3724 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20110227002.pdf [firstpage_image] =>[orig_patent_app_number] => 13152600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201144 [patent_doc_number] => 08188110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Morphinan compounds' [patent_app_type] => utility [patent_app_number] => 13/118912 [patent_app_country] => US [patent_app_date] => 2011-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16167 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188110.pdf [firstpage_image] =>[orig_patent_app_number] => 13118912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712304 [patent_doc_number] => 20120004397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'VIOLET LASER EXCITABLE DYES AND THEIR METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 13/149392 [patent_app_country] => US [patent_app_date] => 2011-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21820 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13149392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9046882 [patent_doc_number] => 08541436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Morphinan compounds' [patent_app_type] => utility [patent_app_number] => 13/118935 [patent_app_country] => US [patent_app_date] => 2011-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16211 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13118935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048703 [patent_doc_number] => 20110207763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => '8-CARBOXAMIDO-2,6-METHANO-3-BENZAZOCINES' [patent_app_type] => utility [patent_app_number] => 13/103599 [patent_app_country] => US [patent_app_date] => 2011-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7984 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207763.pdf [firstpage_image] =>[orig_patent_app_number] => 13103599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113095 [patent_doc_number] => 08569265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Deuterated analogs of (4S)-4-ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3′, 4′:6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/068244 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22866 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13068244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733517 [patent_doc_number] => 20120015934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'CYCLOPAMINE LACTAM ANALOGS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/102395 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17116 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015934.pdf [firstpage_image] =>[orig_patent_app_number] => 13102395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090576 [patent_doc_number] => 20110218186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/097940 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 177066 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218186.pdf [firstpage_image] =>[orig_patent_app_number] => 13097940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574308 [patent_doc_number] => 20110269964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'N-Alkylation of Opiates' [patent_app_type] => utility [patent_app_number] => 13/095952 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7834 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269964.pdf [firstpage_image] =>[orig_patent_app_number] => 13095952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574307 [patent_doc_number] => 20110269963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Preparation of Saturated Ketone Morphinan Compounds Having Low Metal Content' [patent_app_type] => utility [patent_app_number] => 13/093892 [patent_app_country] => US [patent_app_date] => 2011-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7364 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269963.pdf [firstpage_image] =>[orig_patent_app_number] => 13093892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549357 [patent_doc_number] => 08324239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Furopyridine compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/089764 [patent_app_country] => US [patent_app_date] => 2011-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57045 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13089764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167705 [patent_doc_number] => 20110195990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'TREATMENT OF RESISTANT OR REFRACTORY CANCERS WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN' [patent_app_type] => utility [patent_app_number] => 13/088825 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10046 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195990.pdf [firstpage_image] =>[orig_patent_app_number] => 13088825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113964 [patent_doc_number] => 20110190387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHOD FOR TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT' [patent_app_type] => utility [patent_app_number] => 13/086277 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5998 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190387.pdf [firstpage_image] =>[orig_patent_app_number] => 13086277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8733795 [patent_doc_number] => 20130079364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'Peripheral Opioid Agonists and Peripheral Opioid Antagonists' [patent_app_type] => utility [patent_app_number] => 13/634532 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34903 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725588 [patent_doc_number] => 08404706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Opioid and opioid-like compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/081179 [patent_app_country] => US [patent_app_date] => 2011-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12257 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13081179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199545 [patent_doc_number] => 20120122909 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-05-17 [patent_title] => 'SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/078678 [patent_app_country] => US [patent_app_date] => 2011-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 144453 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0122/20120122909.pdf [firstpage_image] =>[orig_patent_app_number] => 13078678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199545 [patent_doc_number] => 20120122909 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2012-05-17 [patent_title] => 'SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/078678 [patent_app_country] => US [patent_app_date] => 2011-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 144453 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0122/20120122909.pdf [firstpage_image] =>[orig_patent_app_number] => 13078678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503401 [patent_doc_number] => 20120302809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'PRODUCTION OF ALPHA-OLEFINS' [patent_app_type] => utility [patent_app_number] => 13/576732 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4852 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13576732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488484 [patent_doc_number] => 20110251391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'Preparation of luminescent iridium complexes and precursors thereof' [patent_app_type] => utility [patent_app_number] => 13/064401 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6047 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251391.pdf [firstpage_image] =>[orig_patent_app_number] => 13064401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8177651 [patent_doc_number] => 08178676 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Pyridinium boronic acid quenchers for use in analyte sensors' [patent_app_type] => utility [patent_app_number] => 13/069150 [patent_app_country] => US [patent_app_date] => 2011-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9929 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178676.pdf [firstpage_image] =>[orig_patent_app_number] => 13069150 [rel_patent_id] =>[rel_patent_doc_number] =>)